City
Epaper

Ayush Ministry will clear stance on Patanjali's COVID-19 medicines after reviewing its report: Shripad Naik

By ANI | Published: June 24, 2020 11:06 AM

MoS for the Union Ayush Ministry Shripad Naik on Wednesday said that his Ministry will clear its stance on pharmaceutical giant Patanjali's newly-launched ayurvedic drugs 'Coronil and Swasari' for the novel coronavirus after reviewing the report sent by it.

Open in App

MoS for the Union Ayush Ministry Shripad Naik on Wednesday said that his Ministry will clear its stance on pharmaceutical giant Patanjali's newly-launched ayurvedic drugs 'Coronil and Swasari' for the novel coronavirus after reviewing the report sent by it.

However, the Minister said that it is good that Baba Ramdev has given a new medicine to the country.

"It is a good thing that Baba Ramdev has given a new medicine to the country but as per rule, it has to come to AYUSH Ministry first. They even said that they have sent a report. We will look into it and permission will be given after seeing the report," Naik told .

The AYUSH Ministry had said on Tuesday that it has taken cognizance of news in the media about Ayurvedic medicines developed for the treatment of COVID-19 by Patanjali Ayurved Ltd, Haridwar and said the company has been asked to "stop advertising/publicising such claims till the issue is duly examined".

In a release, the Ministry said that facts of the claim and details of the stated scientific study are not known to it.It had said the concerned Ayurvedic drug manufacturing company has been informed that such advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and directives issued by the Central government in the wake of COVID outbreak.The Ministry had also issued a notification in April stating the requirements and the manner in which the research studies on COVID-19 with AYUSH interventions/medicines should be undertaken.The release had said that Patanjali Ayurved has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment, places where the research study was conducted for COVID-19, protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results from data of the study and "stop advertising/publicising such claims till the issue is duly examined.The Ministry had also requested concerned state licensing authority of Uttrakhand to provide copies of license and product approval details of Ayurvedic medicines being claimed for the treatment of COVID-19.Patanjali Ayurved on Tuesday launched 'Coronil and Swasari' claiming it to be Ayurvedic cure for treating COVID-19 and said clinical trials have shown favourable results.

( With inputs from ANI )

Tags: MinistryBaba RamdevAyush Ministry
Open in App

Related Stories

NationalPatanjali Misleading Ads Case: Supreme Court Adjourns Verdict on Contempt Notice Against Baba Ramdev and Others

NationalPatanjali Foods Gets Show Cause Notice for GST Dues Over Rs 27.46 Crore Input Tax Credit

NationalUttarakhand Government Suspends Licenses of 14 Patanjali Products Over Misleading Ads

NationalPatanjali Misleading Advertisements Case: Ramdev, Balkrishna Issue Fresh Apology After Supreme Court Rap

National‘You Are Not Innocent’: Supreme Court Tells Yoga Guru Ramdev, He Says Will Remain Conscious in Future

National Realted Stories

NationalINDIA bloc claims 'acche din' to start from June 4, will win 46 of 48 LS seats in Maha

NationalBJP Grows Beyond Dependence on RSS, Says JP Nadda

NationalSex scandal: No objection to action against Prajwal; people know how HD Revanna’s case is being dealt, says former PM Deve Gowda

NationalGujarat: Computer Operator Arrested for Rs 5 Bribe in Jamnagar Village

NationalNarcotics seized, one arrested in Assam's Karbi Anglong